EP 3946378 A1 20220209 - DEXTRAN SULFATE FOR INFLAMMATORY SKIN CONDITIONS
Title (en)
DEXTRAN SULFATE FOR INFLAMMATORY SKIN CONDITIONS
Title (de)
DEXTRANSULFAT FÜR ENTZÜNDLICHE HAUTKRANKHEITEN
Title (fr)
SULFATE DE DEXTRAN DANS LES DERMATOSES INFLAMMATOIRES
Publication
Application
Priority
- FR 1903628 A 20190404
- EP 2020059527 W 20200403
Abstract (en)
[origin: WO2020201492A1] The invention relates to the use of dextran sulfate and to a dermatological composition or dermo-cosmetic composition containing dextran sulfate, in the treatment and/or prevention of inflammatory skin conditions, particularly atopic dermatitis.
IPC 8 full level
A61K 31/737 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 17/10 (2006.01)
CPC (source: EP KR US)
A61K 8/73 (2013.01 - KR); A61K 31/737 (2013.01 - EP KR US); A61K 36/21 (2013.01 - US); A61P 17/00 (2017.12 - EP KR US); A61P 17/06 (2017.12 - EP KR); A61P 17/10 (2017.12 - EP KR); A61P 29/00 (2017.12 - KR); A61Q 19/00 (2013.01 - KR); A61K 2236/19 (2013.01 - US)
Citation (search report)
See references of WO 2020201492A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020201492 A1 20201008; CA 3135889 A1 20201008; CN 113766922 A 20211207; EP 3946378 A1 20220209; FR 3094637 A1 20201009; JP 2022527851 A 20220606; KR 20210148183 A 20211207; MX 2021011999 A 20211117; US 2022175820 A1 20220609
DOCDB simple family (application)
EP 2020059527 W 20200403; CA 3135889 A 20200403; CN 202080032074 A 20200403; EP 20714649 A 20200403; FR 1903628 A 20190404; JP 2021560214 A 20200403; KR 20217033091 A 20200403; MX 2021011999 A 20200403; US 202017600766 A 20200403